Related Experiment Video
Updated: May 29, 2026
04:11
Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
[Hepatitis C in Poland in 2009].
Magdalena Rosińska1, Małgorzata Stepień
1Zakład Epidemiologii Narodowego Instytutu Zdrowia Publicznego--Państwowego Zakładu Higieny w Warszawie. mrosinska@pzh.gov.pl
Przeglad Epidemiologiczny
|September 15, 2011
Summary
Poland observed a decrease in hepatitis C incidence and mortality in 2009, with improved treatment accessibility likely contributing to reduced deaths. Case definitions require refinement for accurate trend monitoring.
Area of Science:
- Epidemiology
- Public Health
- Virology
Context:
- In 2009, Poland utilized two distinct case definitions for reporting hepatitis C cases.
- The 2005 definition included clinical signs or elevated liver function tests confirmed by antibody tests.
- The 2009 definition encompassed all laboratory-confirmed cases.
Purpose:
- To analyze and compare hepatitis C case reporting using two different definitions in Poland.
- To assess the incidence and mortality trends of hepatitis C in Poland for 2009.
- To evaluate the effectiveness of case definitions in monitoring hepatitis C trends and disease burden.
Summary:
- In 2009, Poland registered 1,939 hepatitis C cases using the 2005 definition (incidence rate: 5.08/100,000), continuing a downward trend since 2006.
- Under the 2009 definition, 1,891 laboratory-confirmed cases were reported, highlighting potential reporting completeness issues.
- Hepatitis C mortality decreased significantly in 2009, with 82 deaths (2 acute, 80 chronic), marking the first substantial reduction since 1996.
Impact:
- The findings underscore the need for improved reporting completeness and suggest the temporary continuation of the 2005 definition for reliable trend monitoring.
- The observed decrease in mortality coincides with enhanced treatment accessibility, suggesting a positive impact of improved care.
- This study provides crucial data for public health strategies aimed at controlling and eliminating hepatitis C in Poland.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...